Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ortho-McNeil scientists discover new androgen receptor modulators

Dec. 5, 2003

Protein prenyltransferase inhibitors newly identified at PPD Discovery

Dec. 5, 2003

In vivo efficacy of drugs targeting tumor vasculature

Dec. 4, 2003

Telcyta awarded fast track status for third-line therapy of NSCLC

Dec. 4, 2003

Xcytrin granted fast track status for brain metastases in NSCLC patients

Dec. 4, 2003

Maxim licenses MX-90745 series to Myriad

Dec. 4, 2003

Rolling NDA submission continues for Onco TCS

Dec. 4, 2003

German approval for Leuprogel one-month depot product

Dec. 4, 2003

New inhibitors of ERK2 and other protein kinases covered by Vertex patent

Dec. 4, 2003

AxyS and Cytovia patent novel caspase activators for use as antitumor agents

Dec. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...